Answer
The most frequently reported adverse reaction to eliglustat tartrate is dyspepsia, reported in approximately 6% of pooled adult clinical trial patients and 10.5% of paediatric patients across both ELIKIDS study cohorts.
Sources for this answer
- Cerdelga 84 mg capsules, hardSANOFI · emc · SmPC §4.8 Undesirable effects · Version 11Document updated
Sources checked